儿童大梗死核心动脉缺血性卒中:取栓与内科治疗比较
该多中心病例对照研究汇总3项儿童卒中队列数据,纳入40例1至18岁前循环大血管闭塞且ASPECTS 0至5分的患儿,比较取栓与单纯内科治疗。取栓组90天儿童改良Rankin量表评分显著优于内科治疗组(OR 3.68,95%CI 1.11-12.21,P=0.034),症状性颅内出血率两组无显著差异(P=0.806)。
要点
- 儿童前循环LVO伴低ASPECTS者,取栓组90天功能结局优于单纯内科治疗。
- 取栓与内科治疗的症状性颅内出血率无显著差异。
- 仅凭低ASPECTS评分将儿童排除于取栓之外可能并不恰当。
核心结论
- 儿童(1-18岁)前循环LVO卒中且ASPECTS 0-5分者,接受取栓者90天功能结局显著优于单纯内科治疗。
- 仅依据低ASPECTS评分将儿童排除于取栓之外可能并不恰当。
研究设计与样本
- 多中心病例对照研究,汇总Save ChildS、Save ChildS Pro与Pediatric LVO Stroke Study共3项儿童卒中队列数据。
- 纳入2000年1月1日至2023年8月31日来自欧洲、北美和澳大利亚45个中心的56例患儿,其中40例符合纳入标准。
- 纳入标准为1至18岁、前循环LVO、最后正常时间24小时内、CT或MRI的ASPECTS 0至5分;排除孤立M2闭塞及局灶性脑动脉病炎症亚型。
- 取栓组24例,单纯内科治疗组16例;女性14例(35.0%),平均年龄9.1岁(范围1.5-17,SD 5.27)。
主要发现
- 取栓组90天儿童改良Rankin量表评分显著优于内科治疗组(OR 3.68,95%CI 1.11-12.21;P=0.034)。
- 两组症状性颅内出血率无显著差异(P=0.806)。
关键数值与推荐
- 主要结局为90天儿童改良Rankin量表评分,采用序数logistic回归进行组间比较。
- 取栓组与内科治疗组比较:OR 3.68(95%CI 1.11-12.21),P=0.034。
- 症状性颅内出血组间比较:P=0.806。
临床怎么用
- 对1-18岁前循环LVO且ASPECTS 0-5分的患儿,取栓可作为改善90天功能结局的考虑选项。
- 不应仅因ASPECTS评分低而将儿童卒中患者排除于取栓之外。
- 决策时需结合症状性颅内出血风险评估,该研究中两组出血率无显著差异。
局限性
- 为病例对照研究而非随机对照试验,样本量小(共40例),证据等级有限。
- 数据来自回顾性汇总的多中心队列,可能存在选择偏倚与混杂。
- 孤立M2闭塞及局灶性脑动脉病炎症亚型被排除,结论不能外推至这些人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple recent randomized trials have demonstrated the benefit of thrombectomy over medical management alone in adult patients with large vessel occlusion (LVO) stroke and large infarct on baseline imaging. Cohort studies have also identified improved functional outcomes in pediatric patients who received thrombectomy. However, the role of thrombectomy in pediatric stroke with large baseline infarct remains uncertain. METHODS: A case-control study was undertaken using pooled data from 3 cohort studies of pediatric stroke (Save ChildS [Safety and Outcome of Endovascular Recenalization in Childhood Stroke Study], Save ChildS Pro [Safety and Outcome of Endovascular Recenalization in Childhood Stroke Prospective Registry], Pediatric LVO Stroke Study). Pediatric patients of age 1 to 18 years with acute anterior circulation LVO stroke presenting within 24 hours since last seen well with an Alberta Stroke Program Early CT Score of 0 to 5 on CT or magnetic resonance imaging were included. Isolated M2 occlusion or focal cerebral arteriopathy-inflammatory subtype cases were excluded. Thrombectomy-treated patients were compared with patients who received medical management alone. The primary clinical outcome was the pediatric modified Rankin Scale score at 90 days, compared between groups using ordinal logistic regression. RESULTS: Of 56 pediatric patients with anterior circulation LVO and low Alberta Stroke Program Early CT Score presenting between January 1, 2000 and August 31, 2023 from 45 centers across Europe, North America, and Australia, 40 patients were eligible for inclusion (female: n=14, 35.0%; mean age, 9.1 years; range, 1.5-17; SD, 5.27). Thrombectomy-treated patients (n=24) had significantly better pediatric modified Rankin Scale scores at 90 days than medical management alone patients (n=16; odds ratio, 3.68 [95% CI, 1.11-12.21]; P=0.034). There was no significant difference between groups in the rate of symptomatic intracranial hemorrhage (P=0.806). CONCLUSIONS: In this multicentre case-control study, pediatric patients (age, 1-18 years) with anterior circulation LVO stroke and low Alberta Stroke Program Early CT Score who received thrombectomy had significantly better functional outcomes than those treated with medical management alone. Exclusion of pediatric patients from thrombectomy based on low Alberta Stroke Program Early CT Score alone may not be appropriate.
引用
- Bhatia KD, Muthusami P, Parra-Farinas C, et al. Thrombectomy Versus Medical Management for Pediatric Arterial Ischemic Stroke With Large Baseline Infarct. Stroke. 2025. PMID: 40557480. doi:10.1161/STROKEAHA.125.050993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。